These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 4365622

  • 1. Inhibition of glucagon-mediated increases in hepatic cyclic adenosine 3', 5'-monophosphate by prostaglandin E1 and E2.
    DeRubertis FR, Zenser TV, Curnow RT.
    Endocrinology; 1974 Jul; 95(1):93-101. PubMed ID: 4365622
    [No Abstract] [Full Text] [Related]

  • 2. Glucagon and prostaglandin E1 stimulation of cyclic adenosine 3', 5'-monophosphate levels and adenylate cyclase activity in benign hyperplastic nodules and malignant hepatomas of ethionine-treated rats.
    Chayoth R, Epstein SM, Field JB.
    Cancer Res; 1973 Aug; 33(8):1970-4. PubMed ID: 4352743
    [No Abstract] [Full Text] [Related]

  • 3. Effects of prostaglandins on hepatic adenylate cyclase activity and cyclic adenosine 3',5',-monophosphate content.
    Zenser TV, DeRubertis FR, Curnow RT.
    Endocrinology; 1974 May; 94(5):1404-10. PubMed ID: 4362972
    [No Abstract] [Full Text] [Related]

  • 4. Comparative adenylate cyclase activities in homogenate and plasma membrane fractions of Morris hepatoma 5123tc (h).
    Hickie RA, Jan SH, Datta A.
    Cancer Res; 1975 Mar; 35(3):596-600. PubMed ID: 163685
    [Abstract] [Full Text] [Related]

  • 5. Reduced sensitivity of the hepatic adenylate cyclase-cyclic AMP system to glucagon during sustained hormonal stimulation.
    DeRubertis FR, Craven P.
    J Clin Invest; 1976 Feb; 57(2):435-43. PubMed ID: 176180
    [Abstract] [Full Text] [Related]

  • 6. Comparison of cyclic adenosine 3':5'-monophosphate and cyclic guanosine 3':5'-monophosphate levels, cyclases, and phosphodiesterases in Morris hepatomas and liver.
    Hickie RA, Thompson WJ, Strada SJ, Couture-Murillo B, Morris HP, Robison GA.
    Cancer Res; 1977 Oct; 37(10):3599-606. PubMed ID: 20224
    [No Abstract] [Full Text] [Related]

  • 7. [Cyclic AMP - its importance for clinical medicine].
    Schwarzmeier JD.
    Subsid Med; 1975 Oct; 1-2():21-7. PubMed ID: 163557
    [No Abstract] [Full Text] [Related]

  • 8. The role of cyclic AMP in the regulation of cellular processes.
    Neurosci Res Program Bull; 1970 Jul; 8(3):225-323. PubMed ID: 4342873
    [No Abstract] [Full Text] [Related]

  • 9. Effect of diabetes and insulin on the rat heart adenyl cyclase, cyclic AMP phosphodiesterase and cyclic AMP.
    Das I.
    Horm Metab Res; 1973 Sep; 5(5):330-3. PubMed ID: 4358423
    [No Abstract] [Full Text] [Related]

  • 10. Effects of adrenergic agonists and antagonists on adenylate cyclase activity of dog heart and liver.
    Mayer SE.
    J Pharmacol Exp Ther; 1972 Apr; 181(1):116-25. PubMed ID: 4335168
    [No Abstract] [Full Text] [Related]

  • 11. The action of chlorpromazine on the metabolism of cyclic adenosine 3',5'-monophosphate.
    Wollemann M.
    Adv Biochem Psychopharmacol; 1974 Apr; 9(0):731-8. PubMed ID: 4151772
    [No Abstract] [Full Text] [Related]

  • 12. The effect of glucagon and prostaglandin E1 on cyclic AMP levels in liver of heat exposed hamsters.
    Aharon M, Graziani Y, Chayoth R.
    Acta Endocrinol (Copenh); 1980 Apr; 93(4):475-8. PubMed ID: 6247868
    [Abstract] [Full Text] [Related]

  • 13. Prostaglandin E1: anomalous effects on glucose production in rat liver.
    Wheeler GE, Epand RM.
    Mol Pharmacol; 1975 May; 11(3):335-9. PubMed ID: 167276
    [No Abstract] [Full Text] [Related]

  • 14. Control of hepatic glycogen metabolism in the rhesus monkey: effect of glucose, insulin, and glucagon administration.
    Curnow RT, Rayfield EJ, George DT, Zenser TV, De Rubertis F.
    Am J Physiol; 1975 Jan; 228(1):80-7. PubMed ID: 167592
    [Abstract] [Full Text] [Related]

  • 15. [Mechanism of thrombocyte aggregation inhibition caused by sulfonylurea compounds. 3. Significance of prostaglandins and cAMP for aggregation inhibiting effect and other effects of sulfonylurea compounds].
    Scholz VC, Hoder A, Losert W.
    Arzneimittelforschung; 1975 Mar; 25(3):347-61. PubMed ID: 239727
    [No Abstract] [Full Text] [Related]

  • 16. [Effect of ionizing radiation on the activity of adenylate cyclase, cAMP phosphodiesterase and the level of cAMP in mouse liver].
    Sobolev AS, Orekhov AN, Chirkov IuIu, Tertov VV, Kudriashov IuB.
    Dokl Akad Nauk SSSR; 1977 Mar; 232(6):1445-7. PubMed ID: 192526
    [No Abstract] [Full Text] [Related]

  • 17. Independence of pituitary tumor-mediated suppression of growth hormone secretion and cyclic 3',5'-adenosine monophosphate production.
    MacLeod RM, Lehmeyer JE.
    Cancer Res; 1973 Apr; 33(4):843-8. PubMed ID: 4348775
    [No Abstract] [Full Text] [Related]

  • 18. Evidence for separate sites of action for the antilipolytic effects of insulin and prostaglandin E1.
    Loten EG, Sneyd JG.
    Endocrinology; 1973 Dec; 93(6):1315-22. PubMed ID: 4356613
    [No Abstract] [Full Text] [Related]

  • 19. The developmental formation of enzymes involved in glycogen metabolism.
    Piras R, Piras MM.
    Enzyme; 1973 Dec; 15(1):82-96. PubMed ID: 4361642
    [No Abstract] [Full Text] [Related]

  • 20. The effect of parathyroid hormone on rabbit renal cortex adenyl cyclase during development.
    Linarelli LG, Bobik J, Bobik C.
    Pediatr Res; 1973 Nov; 7(11):878-82. PubMed ID: 4356081
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.